key: cord-0264283-hz8aba2f
authors: Dey, Debabrata; Nunes-Alves, Ariane; Wade, Rebecca C; Schreiber, Gideon
title: The effects of protein crowders on small molecule drug diffusion
date: 2021-12-30
journal: bioRxiv
DOI: 10.1101/2021.12.30.474528
sha: 872e752d32abae304c14092bfebc80ae0c50d249
doc_id: 264283
cord_uid: hz8aba2f

Crowded environments affect the pharmacokinetics of drug molecules. Here, we investigate how three macromolecular protein crowders, bovine serum albumin, hen egg-white lysozyme and myoglobin, influence the translational diffusion rates and interactions of four low molecular-weight drugs, fluorescein, doxorubicin, glycogen synthase kinase-3 inhibitor SB216763 and quinacrine. Using Fluorescence Recovery After Photo-bleaching in Line mode (Line FRAP), Brownian dynamics simulations and molecular docking, we find that the diffusive behavior of the small molecules is highly affected by self-aggregation, interactions with the proteins, and surface adhesion. Fluorescein diffusion is decreased by protein crowders due to their interactions. On the other hand, for doxorubicin, the presence of protein crowders increases diffusion by reducing surface interactions. SB216763 shows a third scenario, where BSA, but not myoglobin or lysozyme, reduces self-aggregation, resulting in faster diffusion. Quinacrine was the only small molecule whose diffusion was not affected by the presence of protein crowders. The mechanistic insights gained here into the effects of interactions of small molecules with proteins and surfaces on the translational diffusion of small molecules can assist in optimizing the design of compounds for higher mobility and lower occlusion in complex macromolecular environments. Significance statement The activity of small molecules is directly related to their active concentration. This, in turn, relates to their molar concentration and their activity coefficient. Any deviations from ideal behavior affects the small molecule activity. This is particularly important for drugs, where we seek to optimize their molar activity. Here, we follow the diffusional activity of four small molecule drugs in various solutions, with and without protein crowders. The study, which involves experimental measurements and theoretical simulations, shows that 3 of the 4 drugs do not diffuse normally, either due to aggregation, protein binding or surface adhesion. We show the mechanisms driving the abnormal diffusion, and how it can be reduced. Lessons learned from this study can be implemented into drug design.

find that the diffusive behavior of the small molecules is highly affected by selfaggregation, interactions with the proteins, and surface adhesion. Fluorescein diffusion is decreased by protein crowders due to their interactions. On the other hand, for doxorubicin, the presence of protein crowders increases diffusion by reducing surface interactions.

SB216763 shows a third scenario, where BSA, but not myoglobin or lysozyme, reduces self-aggregation, resulting in faster diffusion. Quinacrine was the only small molecule whose diffusion was not affected by the presence of protein crowders. The mechanistic insights gained here into the effects of interactions of small molecules with proteins and surfaces on the translational diffusion of small molecules can assist in optimizing the design of compounds for higher mobility and lower occlusion in complex macromolecular environments.

The activity of small molecules is directly related to their active concentration. This, in turn, relates to their molar concentration and their activity coefficient. Any deviations from ideal behavior affects the small molecule activity. This is particularly important for drugs, where we seek to optimize their molar activity. Here, we follow the diffusional activity of four small molecule drugs in various solutions, with and without protein crowders. The study, which involves experimental measurements and theoretical simulations, shows that 3 of the 4 drugs do not diffuse normally, either due to aggregation, protein binding or surface adhesion. We show the mechanisms driving the abnormal diffusion, and how it can be reduced. Lessons learned from this study can be implemented into drug design.

Introduction: 3 Most drugs have molecular weight < 1 kDa and an octanol/water partition (logP) of 1-6 (1) . For a drug to be orally absorbed, it must be hydrophobic to partition into the lipid bilayer, but not to an extent that will result in permanent absorbance into the bilayer (1) .

Overall, this results in drugs that self-associate as well as binding to hydrophobic cellular components through soft interactions (2) , which in turn decrease their active concentration.

In addition to self-aggregation in polar aqueous/buffer-like solvents, small molecule drugs tend to interact with or absorb to glass or plastic surfaces, further complicating diffusion measurements (3) . Overlooking these factors may lead to spurious observations that can negatively impact studies of small molecule drugs (4) (5) (6) (7) . Moreover, while biophysical characterization of these drugs is done in vitro, they are required to be active in a complex, crowded environment, containing membranes and macromolecules at concentrations of up to 300 mg/mL (8) .

For small molecules to reach their target within a crowded milieu, they have to freely diffuse and avoid off-target interactions (9) . Passive diffusion is considered to be a primary mechanism of intracellular drug transport (10) . However, more recently carriermediated transport (10, 11) or a combination of the two were also identified (12) . The study of the diffusion of small organic molecules inside complex environments is therefore highly relevant for drug design (9, 13) , as well as for soft matter and biochemical (14) studies more generally (15). The challenge (16) is that most small molecules are not fluorescent in the visible spectrum, making it almost impossible to follow them by optical methods (17) . Conversely, proteins can usually be fluorescently labeled without significant perturbation of their diffusion rate and function, making it relatively easy to study their diffusion (18) .

Here, we investigated the diffusion of three fluorescent organic small molecule therapeutic drugs and one diagnostic marker in solutions containing proteins as crowders.

Doxorubicin (DOX) is widely used as an anti-cancer agent (19, 20) ; quinacrine dihydrochloride has been used for antimalarial and antiprotozoal therapy (21, 22) ; glycogen synthase kinase-3 (GSK3) inhibitor SB 216763 is a potent selective and ATPcompetitive inhibitor of glycogen synthase kinase-3 and significantly prevents lung inflammation and fibrosis in mouse models (23) (24) (25) . DOX and quinacrine behave as weak bases at physiological pH (26) . Unlike the three therapeutic drugs, fluorescein in its salt 4 form (which is widely used as a biological marker in angiographic assays) is a negatively charged molecule at physiological pH (27, 28) . The four molecules investigated are structurally and chemically different from each other ( Figure 1 ). They were chosen according to their spectral properties, with fluorescence in the visible spectrum being a prerequisite for their application in this study ( Figure 1 ). The diffusion and aggregation of these low MW molecules were evaluated in buffer, and with bovine serum albumin (BSA), hen egg-white lysozyme (HEWL), and myoglobin as molecular crowders (29, 30) . Selfaggregation and binding to these proteins can potentially mimic their behaviors in body fluids or inside the cell (31, 32) . Diffusion rate measurements provide a good proxy for estimating these protein-ligand associations or their aggregation state in diversified environments.

A wide range of computational and experimental techniques have been developed to compute and measure diffusion rates, as well as to study molecular association. On the computational side, Brownian dynamics (BD) (33) and molecular dynamics (MD) (16, 30, (34) (35) (36) simulations are widely used. In both methods, the system can be considered in atomic detail, but in BD simulations, the molecules are generally treated as rigid bodies and an implicit solvation model is used. These simplifications allow BD simulations to routinely achieve tens of microseconds of simulation time with systems containing hundreds of solute molecules. BD simulations have been previously employed to compute diffusional properties of proteins, revealing, for example, molecular details about the reduction in diffusion rates of BSA, myoglobin, hemoglobin and γ-globulin under crowding conditions (37, 38) or the adsorption of HEWL to an inorganic surface (39, 40) .

Among the experimental techniques, fluorescence recovery after photobleaching (FRAP) (41) , fluorescence correlation microscopy (FCS) (42), and single-particle tracking (SPT) (43) are the most popular. Each method has its benefits and limitations (44) . FCS is considered the gold standard for this purpose; however, its application can be challenging.

For one, it requires high quantum yield (which is rare for drugs), second it can be performed only at very low concentrations, which may be much lower compared to that found in vivo.

Therefore, FRAP is the technique most widely used by experimental biologists (44) . It is fast, non-invasive, highly specific, and relatively easy to perform (44) . Moreover, FRAP 5 can be used on molecules with poor quantum yields and at high, biologically relevant concentrations (41) .

We previously developed the Fluorescence Recovery After Photo-bleaching in Line mode (Line FRAP) method to monitor the diffusion rates of proteins in various environments (45) . The main advantage of Line-FRAP over conventional FRAP is the much faster data acquisition rate, which allows measurements for fast diffusing molecules.

The apparent diffusion coefficients calculated from FRAP measurements are Dconfocal (45) , which are calculated according to equation 1:

where 1/2 is the half-time of recovery and re and rn are the effective and nominal bleach radii values. Line-FRAP Dconfocal values were shown to be in line with FCS diffusion rates for proteins (45) . However, for small molecules, they provide only relative 3D diffusion coefficients (46) . An alternative way to present FRAP results is by reporting only τ1/2 values. However, as seen from eq. 1, this completely ignores the contribution from the bleach radius (which is squared) (47, 48) . In particular, re varies, depending on the type of molecule and the diffusion condition, making its measurement critical to obtain reliable estimates of diffusion rates.

In this study, we determined Dconfocal values by Line-FRAP for four small molecule drugs using three different proteins as crowders. The derived diffusion coefficients are shown to depend on the self-aggregation properties of the small molecules, their binding to proteins and surfaces, and the buffer solution conditions. The protein crowders affect the solubility and diffusion rates of the drugs in a manner that is dependent on the properties of the different protein crowders used. Complementary steady-state fluorescence quenching and size exclusion chromatography experiments provide thermodynamic data that reveal differences in the associations between the drug molecules and the protein crowders. Furthermore, Brownian dynamics simulations and molecular docking for the systems studied experimentally shed light on the intermolecular interactions and molecular mechanisms responsible for the differences in the diffusion coefficients measured for the different small molecule and protein crowder combinations.

Fluorescein is a negatively charged organic small molecule (MW = 376.3 Da, Figure 1A ).

As per our stepwise experimental design, we initially measured diffusion rates of fluorescein in PBS buffer with and without protein crowders. Figure 2A shows the calculated diffusion rates in DMSO, PBS and Tween20 and Figure 2B shows micrograph images of fluorescein in the same solutions. Dconfocal of ~56 µm 2 s -1 was determined in all these cases, with no evidence for aggregation of fluorescein. Next, we measured fluorescein's diffusion in the presence of increasing concentrations of BSA, HEWL, and myoglobin ( Figure 2 C-E). Here, we were surprised to see that, even at low concentrations of protein, the presence of BSA, HEWL and myoglobin slowed down diffusion of fluorescein significantly ( Figure 2E ). Since the fraction of excluded volume due to the presence of protein crowders is low at concentrations below 20 mg/mL, we conclude that quinary or weak interactions between fluorescein and the protein crowders are the main drivers of the reduction in the diffusion rates of fluorescein, in line with previous publications (49). HEWL had the biggest effect on diffusion, followed by BSA and myoglobin. Interestingly, for myoglobin, increasing concentrations above 5 mg/mL resulted in an increase in diffusion rates, which returned to their level without crowder at Table S1 ).

Binding of fluorescein to the protein crowders could explain its reduced diffusion in their presence. To explore this further, we first measured Dconfocal of BSA (labelled with CF514 dye) at concentrations between 5-50 mg/mL. Indeed, BSA diffusion is slowed at higher concentrations, probably due to self-crowding ( Figure 2G ). However, diffusion is Oligomerization would lead to an increase in the Stokes radius, resulting in slower diffusion rates. Only a modest reduction in the diffusion coefficient of BSA in the presence of fluorescein with increasing BSA concentration up to 50 mg/mL was observed in BD simulations ( Figure S2 ), again indicating that more extensive aggregation of BSA+fluorescein is present than that captured by the BD rigid body model and force field.

The chemical structure and spectroscopic properties of DOX (MW=580 Da) are shown in Figure 1B . It diffuses surprisingly slowly in PBS buffer, with Dconfocal~ 12.6 µm 2 s -1 ( Figure   4A ), while. the infinite dilution translational diffusion coefficient of DOX (Stokes radius of 5.1 Å), Dtrans, is calculated to be 412 µm 2 s -1 (Table S2) Figure S8 . The data clearly show much slower recovery curves after 63 ms bleach, which are accompanied by a wider bleach radius. However, the Dconfocal values calculated from τ1/2 and re were similar for the different bleach times (Table S3) and G and Table S1), in agreement with a previous study (50) . Figure S3 ) and small, broad RDF peaks for DOX-protein distances ( Figure S4 ). This agrees with the experimental results, which show that the main effect of the protein crowders, especially at low concentrations, is prevention of DOX attachment to the glass surface, rather than slowed diffusion by quinary interactions with protein crowders, as observed for fluorescein. Nonetheless, it should be noted that quinary interactions between DOX and BSA are expected, as reported in a previous study (50) . 

GSK-3 is a protein kinase that is active in a number of central intracellular signaling pathways, including cellular proliferation, migration, glucose regulation, and apoptosis (23) (24) (25) . The GSK-3 inhibitor SB216763 is currently being evaluated for several related malignancies (23) (24) (25) . The chemical structure and spectroscopic properties of SB216763 are shown in Figure 1C . SB216763 has a strong tendency to aggregate in PBS ( Figure 6A ).

Aggregation is also observed in DMEM media. Of the four small molecules tested, the GSK3 inhibitor is the only one with neutral net charge at the pH of the experiments. The lack of repulsive electrostatic interactions may facilitate aggregation. Moreover, BD simulations of the GSK3 inhibitor without protein crowders, showed greater selfinteractions than those observed for the other small molecules (Table S4) Figure 6B to E). Percent FRAP recovery of SB216763 is very low in buffer or in myoglobin, but reaches close to 100% with the addition of 50 mg/mL BSA (see normalized fluorescence in Figure 6B ). Also, Dconfocal is much higher in the presence of 50 mg/mL BSA ( Figure 6C ). FRAP recovery is in line with the micrographs shown in Figure 6A Table S1 ). Thus, while BSA solubilizes SB216763 much better than the other two proteins, we did not find a relation between solubilization of the small molecule and binding affinity.

Visual inspection of the apo and holo crystal structures of the protein crowders shows that myoglobin does not have a crevice or buried binding site for small molecules larger than molecular oxygen, whereas HEWL and BSA do. Moreover, HEWL and BSA were shown to bind to small molecules and act as potential drug carriers (50, 55, 56) .

HEWL can accommodate small molecules in the crevice of its catalytic site, while BSA has four binding cavities that can accommodate small molecules ( Figure 6I ). Docking of the GSK3 inhibitor to BSA and to HEWL shows that the GSK3 inhibitor can bind to one of the cavities of BSA with a good docking score (-9.2 kcal/mol, Figure 6I ) and to the catalytic site of HEWL with a less favorable docking score (-7.9 kcal/mol). The preferable deep binding cavities in BSA that can accommodate the GSK3 inhibitor may explain why BSA is the only protein crowder that can reduce the aggregation of this small molecule.

The diffusion coefficients computed from BD simulations did not show the trends obtained experimentally for the GSK3 inhibitor in the presence of protein crowders ( Figure S1 ), indicating the importance of factors omitted in the BD model, such as small molecule aggregation and binding of small molecules within rather buried cavities in the protein crowder.

Quinacrine dihydrochloride (MW= 472.9 Da), whose chemical structure and spectroscopic properties are shown in Figure 1D , is among the first antimalarial drugs discovered.

Recently, it was also suggested to have high potency against SARS-CoV-2 in an in vitro setting (57, 58) . Quinacrine does not display any significant aggregation issues in buffer solutions (Figure 7 A, B) , and it is not absorbed onto glass surfaces ( Figure 5C ). The addition of BSA, HEWL or myoglobin did not affect its diffusion coefficient (Dconfocal~ 41- Table S1 ).

As in the experiments, computed diffusion coefficients for quinacrine show no significant difference on adding 50 mg/mL protein crowder ( Figure S1 ). One reason for the insensitivity to protein crowders is that quinacrine-protein contacts are less prominent compared to the other small molecules in BD simulations ( Figure S3 ), as also shown by the absence of a peak in the quinacrine-HEWL RDF ( Figure S4 ). However, the number of quinacrine-protein contacts was similar to that for the other small molecules for myoglobin and contacts were more pronounced for BSA. These differences are consistent with the larger positive charge on quinacrine than the other molecules (+2 e), resulting in greater solubility in aqueous solution and a net charge repulsion to HEWL and a net charge attraction to BSA, which however does not result in any significant difference in either the computed or the experimentally determined diffusion coefficients for quinacrine in 50 mg/mL BSA.

We used high-content screening of over 1000 drugs and the database fluorophores.org to search for drugs that are fluorescent in visible light, allowing us to follow their diffusion using FRAP. Of those identified, we chose fluorescein, doxorubicin, SB216763, and quinacrine for this study, as they have moderate to good quantum yields. Diffusion studies involving low MW drugs in multiple environments are rare, mostly as only a few drugs have the desired spectral properties. Still, studying their behavior in aqueous solutions is important as this is the medium for their administration and action. Here, we measured the diffusion of the four molecules in PBS and solutions containing one of three different 14 proteins as crowders, BSA, HEWL, and myoglobin. In addition, we determined the affinity of the small molecule drugs and the three proteins using fluorescence quenching. The equilibrium dissociation constants are moderate (in the range of 1-100 µM). These moderate affinities explain the lack of co-elution in size exclusion chromatography (SEC) of the small molecules to the protein crowders. Co-elution can be observed only for binding affinities better than 0.1 µM, which is not the case here ( Figure S10 , S11 and S12). Yet, the addition of the proteins had a substantial effect on the diffusion of the small molecules. Quinacrine dihydrochloride is a cationic charged, water soluble compound. Its measured diffusion rate is not affected by the glass surface or the protein crowders. Fluorescein is a negatively charged, water-soluble compound. It forms interactions with proteins, which slow down its diffusion, apparently by forming protein-fluorescein oligomeric structures ( Figure 4G ). The opposite is observed for DOX, a positively charged molecule, which diffuses slowly in PBS, but at a faster rate on the addition of protein-crowders. A detailed analysis showed that DOX adsorbs to the glass surface and this is the reason for the slow diffusion. Last, SB216763 is a neutral molecule that is insoluble in water and forms large MW aggregates. However, addition of BSA as carrier protein solubilizes SB216763, as observed from micrographs, the fraction of recovery, the increased diffusion rate, and its ability to dock in a rather buried binding site on BSA.

A point of potential concern is the "slow" measured diffusion coefficients for the small molecules, which are much below those expected. A possible reason could be limitations in the line-FRAP method, which may not allow the measurement of high diffusion coefficients (> 100 µm 2 s -1 ). If this would be a result of a "dead-time" between the end of the bleach and the first recovery data points, we should observe an incomplete bleach (as some recovery occurs before the first data measurement). However, the FRAP curves in Figures 2, 4, 6 and 7 do not show reduced bleach, even for the fastest diffusing molecules. This would suggest that for fast diffusing particles, the data analysis carried out 15 on the experimental observations does not provide absolute diffusion coefficients. Therefore, we name the derived values Dconfocal. However, we consider the relative diffusion rates between the different conditions applied in this study to be robust, as the same data analysis procedure was carried out for all conditions. Unfortunately, methods such as FCS, which could provide an orthogonal approach for diffusion measurements, are not applicable to the small molecules used here, due to their low quantum yield.

In summary, by combining experiments and simulations, we see that the effects of protein crowders on the diffusion of small molecules go beyond the slowing of translational diffusion due to excluded volume, and find that the diffusion of drugs can also be slowed down due to quinary interactions, or it can be increased by surface detachment or a reduction in aggregation of the small molecules ( Figure 8 ).

BSA, myoglobin, and HEWL were purchased from Sigma-Aldrich. Doxorubicin was purchased from AdooQ Bioscience (catalog no. A14403). Fluorescein disodium salt was purchased from chemcruz (catalog no. sc-206026). The GSK3 inhibitor SB216763 (catalog no. ab120202), and quinacrine dihydrochloride (catalog no. ab120749), were purchased from Abcam. All other reagents used are described in a table format (Table S5 , Key resources).

Confocal microscopy. Images were collected with an Olympus IX81 FluoView FV1000 Spectral/SIM Scanner confocal laser-scanning microscope, using 60X DIC oil-immersion objective, N.A. 1.35. For fluorescein disodium salt fluorescence measurements, excitation was done at 440 nm, using a diode laser at an output power of 1-4 % of maximal intensity for high to low concentrations, whereas emission was recorded from 520 to 550 nm using the spectral detection system. For doxorubicin, excitation was done at 515 nm diode laser using 5-10 % of the maximal intensity, and emission were collected from 540-640 nm. For quinacrine di hydro chloride and GSK3 inhibitor, excitation was done at 488 nm laser using 1-2% of the maximal intensity, while emission was collected from 502-560 nm with SDM560 emission dichromator cut off filter. All image analyses were performed using FluoView software, and data analyses were performed using Kaleidagraph software version 4.1 (Synergy).

Line-FRAP was carried out in liquid drops. For photobleaching, "Tornado" of 4 pixels (2x2) diameter was used in the simultaneous stimulus scanner. This is the smallest area achievable using Tornado. The circle area of the bleach was kept precisely in the middle Table S1 .

The initial coordinates for HEWL, BSA and myoglobin were obtained from the PDB files 1HEL (61), 4F5S (62) and 1DWR (63), respectively. Partial atomic charges and protonation states for the protein crowders at pH 7.2 were computed using pdb2pqr (64, 65) . Partial atomic charges for the heme group of myoglobin were obtained from previous work (66) .

The initial coordinates for the small molecules were obtained from conversion of SMILES to PDB format using Babel (67) . The protonation state of the molecules at pH 7.2 was determined using Epik (68) Table S7 ). Hydrodynamic interactions were computed using a mean-field model (38) . The Stokes radii of the small molecules and proteins, necessary to compute hydrodynamic interactions, were calculated from the solvent-accessible volume estimated from a single point Poisson-Boltzmann calculation performed using AMBER 2016 (74) (Table S2) . A radius of four times the Stokes radius of the protein was used to define the local volume for computing hydrodynamic interactions. The forces between molecules were modelled by computing electrostatic interaction, electrostatic desolvation and non-polar desolvation terms from the interactions between the atoms of each molecule and precomputed potential grids on the other molecules. The grid spacing for protein crowders and small molecules was 0.75 Å for simulations with doxorubicin and 0.65 Å for simulations with the other small molecules.

The lengths of the sides of the cubic grids for the small molecules were 97 grid points (electrostatic potential) and 80 grid points (for the other, shorter-range potentials). The lengths of the sides of the cubic grids were 161 grid points (electrostatic potential) and grid 19 135 points (for the other potentials) for HEWL, 225 grid points (electrostatic potential) and 193 grid points (for the other potentials) for BSA, and 225 grid points (electrostatic potential) and 200 grid points (for the other potentials) for myoglobin.

First, all simulated systems were subjected to a 0.2 μs-length BD simulation with interactions between molecules modelled by only a soft-core repulsion energy term in order to resolve any steric clashes in the initial simulation box generated by the SDA tool genbox.

After this, BD production simulations were performed for 10 μs.

The parameters and grids described above were also employed to perform BD simulations in the presence of a silica surface to mimic glass. The parameters for the silica surface were obtained from a previous BD simulation study (40) , and a similar simulation setup was used here. The silica surface was represented as a homogeneously charged graphite lattice surface with a charge density of -0.0013 e/Å 2 . The surface was assigned a charge distribution of -0.0032 e/atom. The x and y dimensions of the simulation box and of the silica surface were 340 Å. The desired crowder concentration was achieved by changing the height (z axis) of the simulation box. In the starting configuration for BD simulations, a buffer region of 120 Å separated the surface and the solutes. Before inclusion of the surface and buffer region in the system, systems were subjected to an initial 0.2 μslength BD simulation with interactions between molecules modelled by only a soft-core repulsion energy term in order to resolve any steric clashes in the initial simulation box.

After this, BD production simulations were performed for 10 μs.

In the analysis of molecule adsorption, a molecule was considered adsorbed when its distance from the surface was less than 4 times the Stokes radius of the molecule, as done previously (40) .

For all BD simulations, radial distribution functions and the number of small molecule-protein or small molecule-small molecule contact interactions were computed using SDA7. Contacts were defined as present when heavy atoms (at least one in each molecule) were within a distance of 4.5 Å of each other. Snapshots were analysed at intervals of 500 picoseconds and values averaged over the last 10 microseconds of the simulations. 20 HYDROPRO(73) was parameterized to reproduce the experimental translational and rotational diffusion coefficients of proteins. One parameter, the radius of the atomic elements (AER), was adjusted to reproduce the experimental results. A procedure similar to that followed in the original publication (73) was followed to obtain an AER value for small molecules: Following the procedure above, an AER of 1.2 Å was obtained for small molecules. Table S7 shows the computed diffusion coefficients for molecules with known experimental diffusion coefficients using AER values before and after the reparameterization for small molecules. . Docking of the GSK3 inhibitor (in pink) to BSA (PDB 4F5S) was performed using different grid centers to capture each of the four binding sites for 3,5diiodosalicylic acid . In one of the binding sites, the GSK3 inhibitor occupied a position similar to that of 3,5-diiodosalicylic acid, showing that the GSK3 inhibitor can bind to a rather buried binding site of BSA. The effects of protein crowders go beyond the slower diffusion due to excluded volume; the diffusion of small molecules can also be slowed down due to quinary interactions, or it can be increased by surface detachment or reduced aggregation of the small molecules. The specific effect of the protein crowder on the translational diffusion coefficient of the small molecule depends on the physico-chemical properties of the crowder and of the small molecule.

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

Surface active drugs: self-association and interaction with membranes and surfactants. Physicochemical and biological aspects

Prevention of doxorubicin sorptive losses in drug delivery studies using polyethylene glycol

A high-throughput screen for aggregation-based inhibition in a large compound library

A detergent-based assay for the detection of promiscuous inhibitors

Apparent activity in high-throughput screening: origins of compound-dependent assay interference

Colloidal aggregation affects the efficacy of anticancer drugs in cell culture

Estimation of macromolecule concentrations and excluded volume effects for the cytoplasm of Escherichia coli

Diffusion of the small, very polar, drug piracetam through a lipid bilayer: an MD simulation study

Evidence-based approach to assess passive diffusion and carriermediated drug transport

Carrier-mediated cellular uptake of pharmaceutical drugs: An exception or the rule?

Coexistence of passive and carrier-mediated processes in drug transport

Molecular Modeling to Estimate the Diffusion Coefficients of Drugs and Other Small Molecules

Enzyme localization, crowding, and buffers collectively modulate diffusion-influenced signal transduction: Insights from continuum diffusion modeling

Entropic diffusion in confined soft-matter and biological systems

Challenges and opportunities in connecting simulations with experiments via molecular dynamics of cellular environments

Fluorescence techniques for drug delivery research: Theory and practice

Recent progress in enzymatic protein labelling techniques and their applications

Pharmacokinetics and metabolism of anthracyclines

Doxorubicin: The Good, the Bad and the Ugly Effect

Beyond DNA binding -A review of the potential mechanisms mediating quinacrine's therapeutic activities in parasitic infections, inflammation, and cancers

New hopes from old drugs: Revisiting DNA-binding small molecules as anticancer agents

Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription

Discovery and Development of GSK3 Inhibitors for the Treatment of Type 2 Diabetes

Lenticular mitoprotection. Part B: GSK-3β and regulation of mitochondrial permeability transition for lens epithelial cells in atmospheric oxygen

Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome dependent cancer multidrug resistance

Complications of intravenous fluorescein injections

Safety of sodium fluorescein for in vivo study of skin

Protein crowding tunes protein stability

Variable interactions between protein crowders and biomolecular solutes are important in understanding cellular crowding

Identification and prediction of promiscuous aggregating inhibitors among known drugs

Colloid formation by drugs in simulated intestinal fluid

Optimal estimates of self-diffusion coefficients from molecular dynamics simulations

Systematic errors in diffusion coefficients from long-time molecular dynamics simulations at constant pressure

Reduced efficacy of a Src kinase inhibitor in crowded protein solution

The shape of protein crowders is a major determinant of protein diffusion

Atomic detail brownian dynamics simulations of concentrated protein solutions with a mean field treatment of hydrodynamic interactions

When the Label Matters: Adsorption of Labeled and Unlabeled Proteins on Charged Surfaces

Brownian Dynamics Simulations of Proteins in the Presence of Surfaces: Long-Range Electrostatics and Mean-Field Hydrodynamics

Fluorescence recovery after photobleaching in material and life sciences: Putting theory into practice

Molecular crowding reduces to a similar extent the diffusion of small solutes and macromolecules: Measurement by fluorescence correlation spectroscopy

High-density mapping of single-molecule trajectories with photoactivated localization microscopy

FRAP in pharmaceutical research: Practical guidelines and applications in drug delivery

Line-FRAP, A Versatile Method to Measure Diffusion Rates In Vitro and In Vivo

3D brownian diffusion of submicron-sized particle clusters

Mobility measurement by analysis of fluorescence photobleaching recovery kinetics

Theoretical analysis of fluorescence photobleaching recovery experiments

Dynamic cluster formation determines viscosity and diffusion in dense protein solutions

Probing the binding sites of antibiotic drugs doxorubicin and N-(trifluoroacetyl) doxorubicin with human and bovine serum albumins

A permeation method for detection of selfaggregation of doxorubicin in aqueous environment

Bovine Serum Albumin Adsorption at a Silica Surface Explored by Simulation and Experiment

The diffusion of doxorubicin drug molecules in silica nanoslits is non-Gaussian, intermittent and anticorrelated

Lysozyme adsorption at a silica surface using simulation and experiment: Effects of pH on protein layer structure

Lysozyme and Human Serum Albumin Proteins as Potential Nitric Oxide Cardiovascular Drug Carriers: Theoretical and Experimental Investigation

Interaction of mycotoxin alternariol with serum albumin

Quinacrine, an antimalarial drug with strong activity inhibiting sars-cov-2 viral replication in vitro

Quinacrine as a potential treatment for COVID-19 virus infection

Fluorescence quenching and ligand binding: A critical discussion of a popular methodology

A critical view on the analysis of fluorescence quenching data for determining ligand-protein binding affinity

Structural and thermodynamic analysis of compensating mutations within the core of chicken egg white lysozyme

Structures of bovine, equine and leporine serum albumin

Structure of a ligand-binding intermediate in wild-type carbonmonoxy myoglobin

PDB2PQR: An automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations

Web servers and services for electrostatics calculations with APBS and PDB2PQR

An Examination of Conformational Flexibility in Porphyrins and Bulky-Ligand Binding in Myoglobin

Open Babel: An Open chemical toolbox

Epik: A software program for pKa prediction and protonation state generation for drug-like molecules

A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: The RESP model

Application of RESP Charges To Calculate Conformational Energies, Hydrogen Bond Energies, and Free Energies of Solvation

SDA 7: A modular and parallel implementation of the simulation of diffusional association software

Calculation of hydrodynamic properties of globular proteins from their atomic-level structure

AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading

Crystallographic studies of the complexes of bovine and equine serum albumin with 3,5-diiodosalicylic acid